News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Actavis Names Claudio Albrecht New Chief Executive
June 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES NEWSWIRES -- Icelandic generic drug maker Actavis Group (ACT-IC) Wednesday named Claudio Albrecht as new chief executive, succeeding Sigurdur Oli Olafsson, who is stepping down after working for the company for seven years.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
May 29, 2026
·
2 min read
·
Tristan Manalac
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
May 28, 2026
·
2 min read
·
Tristan Manalac
Insights
France’s biotech ecosystem: science, capital and scale
May 28, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Vaccines
Lilly just bought renowned regulator Peter Marks a pipeline to play with
May 27, 2026
·
2 min read
·
Annalee Armstrong
